For clinical trial reform, we need more hobbits

I have been thinking about how to make clinical development more efficient for a while now, at least since September last year, when I helped co-organize the Clinical Trial Abundance Initiative. But the process since has been torturous. One might ask: “Why? Why is it so torturous to think about how clinical development can be made more efficient?”. The simple answer lies in the fact that everything surrounding this topic lies in the world of whispers. You talk to someone working as a practitione...